Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.

Conditions

• Advanced Solid Tumor

Interventions

• DRUG: OMTX705
• DRUG: Pembrolizumab
• DRUG: OMTX705
• DRUG: OMTX705
• DRUG: OMTX705
• DRUG: Tislelizumab (BGB-A317)
• DRUG: OMTX705

Sponsor

Oncomatryx Biopharma S.L.

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]